Actavis
Pharmaceutical ManufacturingDublin, Ireland1001-5000 Employees
We would like to invite you to follow our new Allergan page at https://www.linkedin.com/company/allergan?trk=top_nav_home
Growth and Expansion Allergan's recent expansion of manufacturing facilities in Kansas City Missouri indicates ongoing growth and increased production capacity, presenting opportunities for suppliers involved in manufacturing equipment, logistics, and supply chain management.
Innovative Product Launches The launch of new aesthetic and surgical products such as the TissuGlu Surgical Adhesive and JUVÉDERM VOLUX shows Allergan’s focus on advanced medical solutions, creating potential for partnerships with R&D firms, suppliers of medical devices, and marketing agencies.
Focus on Aesthetics Allergan's extensive work on aesthetic products and global trends reports position the company for continued growth in the aesthetics market, offering sales opportunities in beauty tech, skincare, and consumer health sectors.
Regulatory and Recall Management The recent recall of BIOCELL textured breast implants underscores the importance of compliance and quality assurance, which could open doors for consultants, safety testing companies, and regulatory compliance service providers.
Financial Stability With an estimated revenue exceeding 10 billion dollars, Allergan remains financially robust, enabling upselling of sophisticated pharmaceutical solutions, digital marketing tools, and enterprise software to support their large-scale operations.
Actavis uses 8 technology products and services including Hotjar, jsDelivr, Backbone.js, and more. Explore Actavis's tech stack below.
| Actavis Email Formats | Percentage |
| Last_First@allergan.com | 63% |
| First.Last@allergan.com | 28% |
| First_Last@allergan.com | 5% |
| LastFirst@allergan.com | 4% |
Pharmaceutical ManufacturingDublin, Ireland1001-5000 Employees
We would like to invite you to follow our new Allergan page at https://www.linkedin.com/company/allergan?trk=top_nav_home
Actavis's revenue is estimated to be in the range of $10B
Actavis's revenue is estimated to be in the range of $10B